Glucocorticoid Receptor Regulates and Interacts with LEDGF/p75 to Promote Docetaxel Resistance in Prostate Cancer Cells

Patients with advanced prostate cancer (PCa) invariably develop resistance to anti-androgen therapy and taxane-based chemotherapy. Glucocorticoid receptor (GR) has been implicated in PCa therapy resistance; however, the mechanisms underlying GR-mediated chemoresistance remain unclear. Lens epitheliu...

Full description

Bibliographic Details

Published in:	Cells
Main Authors:	Evelyn S. Sanchez-Hernandez, Pedro T. Ochoa, Tise Suzuki, Greisha L. Ortiz-Hernandez, Juli J. Unternaehrer, Hossam R. Alkashgari, Carlos J. Diaz Osterman, Shannalee R. Martinez, Zhong Chen, Isaac Kremsky, Charles Wang, Carlos A. Casiano
Format:	Article
Language:	English
Published:	MDPI AG 2023-08-01
Subjects:	autoantibodies chemoresistance docetaxel exicorilant glucocorticoid receptor LEDGF/p75
Online Access:	https://www.mdpi.com/2073-4409/12/16/2046